Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating activities:
Net loss	$ (2,662,111)	$ (3,462,012)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization and depreciation	124,329	140,836
Non-cash issuance of stock options and warrants	140,370	349,853
Amortization of derivative and warrant liabilities discount	699,957	850,691
Amortization of deferred debt issuance costs and original issue discount	262,520	197,608
Change in fair value of derivative and warrant liabilities	(353,315)	168,471
Gain on extinguishment of debt	$ (119,369)	(227,259)
Fair market value of common stock issued for services		50,000
Changes in assets and liabilities:
Accounts receivable		60,000
Inventory	$ (20,224)	(69,247)
Prepaid expense and other assets	(64,146)	(26,966)
Accounts payable	(43,245)	(222,927)
Accrued expenses	481,516	317,271
Net cash used in operating activities	$ (1,553,718)	(1,873,681)
Investing activities:
Purchases of fixed assets		(6,275)
Net cash used in investing activities		(6,275)
Financing activities:
Proceeds from issuance of convertible notes payable	$ 1,520,250	1,856,376
Payments against note payable to affiliate		(30,000)
Proceeds from exercise of stock options	$ 4,500	18,624
Debt issuance costs	(139,500)	(158,000)
Net cash provided by financing activities	1,385,250	1,687,000
Net decrease in cash	(168,468)	(192,956)
Cash, beginning of year	223,529	236,597
Cash, end of period	55,061	$ 43,641
Cash paid during the period for:
Interest	$ 8,000
Income taxes
Non Cash Investing and Financing Activities:
Conversion of convertible notes to common stock	$ 130,777	$ 236,842
Conversion of interest due on convertible notes to common stock	27,062	52,972
Warrant valuation on issuance of convertible debentures	225,700	$ 897,712
Conversion of accrued interest to note payable	$ 15,000
Elimination of derivative liabilities on conversion		$ 190,337